Company: LCTX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0000950170-25-060090
Chunk: 15

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 15
---
 | $               | 71,558 |     | $     | 129,058 |
| Don M. Bailey                    |     | $           |  67,500 |     | $               | 71,558 |     | $     | 139,058 |
| Neal C. Bradsher                 |     | $           |  72,500 |     | $               | 71,558 |     | $     | 144,058 |
| Anula Jayasuriya                 |     | $           |  57,500 |     | $               | 71,558 |     | $     | 129,058 |
| Alfred D. Kingsley (2)           |     | $           |  53,668 |     | $               |      — |     | $     |  53,668 |
| Michael H. Mulroy                |     | $           | 107,679 |     | $               | 71,558 |     | $     | 179,237 |
| Angus C. Russell                 |     | $           |  71,250 |     | $               | 71,558 |     | $     | 142,808 |

(1) The dollar amounts in this column represent the aggregate fair market value of such awards determined based on the price of our common shares on the grant date in accordance with ASC Topic 718, Compensation-Stock Compensation (ASC Topic 718) . See Note 11 Stock-Based Awards to our consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 for details as to the assumptions used to determine the fair value of the awards. As of December 31, 2024, the aggregate number of common shares subject to stock options outstanding for Mses. Andrews, Amin and Jayasuriya and Messrs. Bailey, Bradsher, Mulroy, and Russell was 305,000, 315,000, 315,000, 365,000, 305,000, 305,000 and 305,000, respectively. (2) Mr. Kingsley passed away in April 2024.

<div align='center'>-9-

CORPORATE GOVERNANCE</div>

General

We believe that good corporate governance is important to ensure that Lineage is managed for the long-term benefit of its shareholders. We periodically review our corporate governance policies and practices.

The Board of Directors’